SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Friday reported a loss of $178.9 million in its fourth quarter.
On a per-share basis, the Salt Lake City-based company said it had a loss of 53 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The biotechnology company posted revenue of $4.5 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $28.7 million.
For the year, the company reported a loss of $463.7 million, or $1.69 per share. Revenue was reported as $58.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
